Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010–2016): concomitant analysis of oritavancin in vitro activity

References

• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.
   PubMed Web of Science ®Google Scholar
• Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34:2588–95.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, Micek ST, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62:130–5.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Moehring RW, Sloane R, Schmader KE, Weber DJ, Fowler VG Jr, et al. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS One 2014;9:e91713.
   PubMed Web of Science ®Google Scholar
• Wang SH, Hines L, van Balen J, Mediavilla JR, Pan X, Hoet AE, et al. Molecular and clinical characteristics of hospital and community onset methicillin-resistant Staphylococcus aureus strains associated with bloodstream infections. J Clin Microbiol. 2015;53:1599–608.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.
   PubMed Web of Science ®Google Scholar
• Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–63.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Farrell DJ, Flamm RK, Sader HS, Jones RN. Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency. J Antimicrob Chemother. 2016;71:3453–8.
   PubMed Web of Science ®Google Scholar
• Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. 9th ed. Washington D.C.: ASM Press; 2007.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 25th informational supplement. M100-S25. Wayne, PA, USA: CLSI; 2015.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 27th informational supplement. M100-S27. Wayne, PA, USA: CLSI; 2017.
   Google Scholar
• EUCAST. Breakpoint tables for interpretation of MIC's and zone diameters. Version 7.1, March 2017, 2017. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_7.1_Breakpoint_Tables.pdf. Accessed March 2017.
   Google Scholar
• Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis. 2004;50:59–69.
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Gaynes RP; National Nosocomial Infections Surveillance System. The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis. 2008;47:927–30.
   PubMed Web of Science ®Google Scholar
• Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA 2010;304:641–8.
   PubMed Web of Science ®Google Scholar
• Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173:1970–8.
   PubMed Web of Science ®Google Scholar
• Liebowitz LD. MRSA burden and interventions. Int J Antimicrob Agents 2009;34:S11–S13.
   PubMed Web of Science ®Google Scholar
• Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother. 2012;67:802–9.
   PubMed Web of Science ®Google Scholar
• Nielsen SL, Pedersen C, Jensen TG, Gradel KO, Kolmos HJ, Lassen AT. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014;69:51–9.
   PubMed Web of Science ®Google Scholar
• Blomfeldt A, Eskesen AN, Aamot HV, Leegaard TM, Bjornholt JV. Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality. Eur J Clin Microbiol Infect Dis. 2016;35:803–13.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect. 2011;17:513–l8.
   PubMed Web of Science ®Google Scholar
• Benfield T, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, Pallesen LV, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007;13:257–63.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect. 2013;19:860–8.
   PubMed Web of Science ®Google Scholar
• ECDC. Summary of the latest data on antibiotic resistance in the European Union, EARS-NET surveillance data, 2016. Available from: http://ecdc.europa.eu/en/eaad/Documents/antibiotics-EARS-Net-summary-2016.pdf.
   Google Scholar
• Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE. Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. Clin Infect Dis. 2012;54:S233–S238.
   PubMed Web of Science ®Google Scholar
• Garcia-Vazquez E, Fernandez-Rufete A, Hernandez-Torres A, Canteras M, Ruiz J, Gomez J. When is coagulase-negative Staphylococcus bacteraemia clinically significant? Scand J Infect Dis. 2013;45:664–71.
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob. 2004;3:7.
   PubMedGoogle Scholar
• Elouennass M, Sahnoun I, Zrara A, Bajjou T, Elhamzaoui S. Epidemiology and susceptibility profile of blood culture isolates in an intensive care unit (2002–2005). Med Mal Infect. 2008;38:18–24.
   PubMed Web of Science ®Google Scholar
• Syrjala H, Ohtonen P, Kinnunen U, Raty R, Elonen E, Nousiainen T, et al. Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters. Eur J Clin Microbiol Infect Dis. 2010;29:1211–18.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Verhoef J, Schmitz FJ; European SP. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997–1998. Eur J Clin Microbiol Infect Dis. 2001;20:617–25.
   PubMed Web of Science ®Google Scholar
• Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol. 1998;19:581–9.
   PubMed Web of Science ®Google Scholar
• Wang IK, Chang YC, Liang CC, Chuang FR, Chang CT, Lin HH, et al. Bacteremia in hemodialysis and peritoneal dialysis patients. Intern Med. 2012;51:1015–21.
   PubMed Web of Science ®Google Scholar
• Aust C, Tolfvenstam T, Broliden K, Ljungman P, Kalin M, Giske CG, et al. Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns. Scand J Infect Dis. 2013;45:285–91.
   PubMed Web of Science ®Google Scholar
• Han SB, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, et al. Clinical characteristics and antimicrobial susceptibilities of viridans Streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children. BMC Infect Dis. 2013;13:273.
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Orgel E, Rushing T, Fu C, Hoffman JA. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia. Pediatr Infect Dis J. 2015;34:e78–e84.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Bodro M, Simonetti A, Tubau F, Gonzalez-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19:474–9.
   PubMed Web of Science ®Google Scholar
• Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med. 2002;112:622–6.
   PubMed Web of Science ®Google Scholar
• Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control. 2007;35:73–85.
   PubMed Web of Science ®Google Scholar